NEAUVIA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10961
Neauvia Stimulate
In stock
Volume
1 x 1 mL
Laboratory
Matex Lab S.P.A
Origin
イタリア
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Neauvia Stimulate is a biodegradable hyaluronic acid filler cross-linked with PEG and enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy, intended to restore lost volume of the soft tissue and resorbed over time. It is placed in the subdermis and over the periosteum. The product contains 26 mg/mL of hyaluronic acid with a medium to high extrusion force, is enriched with glycine and L-proline and is intended for professional use. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market, and Stimulate was named Best Injectable Dermal Filler at the AMWC 2024 Awards.
主なメリット： Neauvia Stimulate
- 26 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- One of the only PEG-HA plus CaHA fillers on the market
- Named Best Injectable Dermal Filler at the AMWC 2024 Awards
- Studied over 24 weeks for correction of mid-face volume deficit
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
適応と専門的な使用
主な適応
- Restoration of lost volume of the soft tissue
- Correction of mid-face volume deficit
専門的な使用
For professional use. Neauvia Stimulate is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices, and it is the filler used in Neauvia's Nlift mid-face synergistic protocol.
施術部位
- Face
- Mid-face
対象となる患者
Suitable for adult patients presenting with age-related volume loss of the soft tissue, particularly mid-face volume deficit, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
作用の仕組み： Neauvia Stimulate
Stimulate combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. A 24-week post-market, observational, prospective, open-label, single-centre study reported that this formulation effectively addresses skin and subcutaneous tissue concerns, in particular the correction of disorders and of mid-face volume deficit, with the data highlighting an efficient mechanical effect of the PEGylated polymeric acid matrix enriched with low-concentration CaHA. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance. The gel is a temporary filling, with a 6 month degradation average time.
Allparaで注文する理由
Allparaは、正規品で検証済みの NEAUVIA 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。
よくある質問
How does Neauvia Stimulate differ from Neauvia Intense?
Composition and plane. Neauvia Stimulate carries 26 mg/mL hyaluronic acid enriched with calcium hydroxyapatite and is placed in the subdermis or over the periosteum. Neauvia Intense carries 28 mg/mL without CaHA and is placed in the subcutis or over the periosteum. The Stimulate line is the only one in the range to combine PEG-HA with CaHA.
Why does Neauvia Stimulate contain calcium hydroxyapatite?
A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue, in particular for correcting mid-face volume deficit.
その他の製品： Matex Lab S.P.A
Clinic alternatives
/ Recently viewed
Pick up where you left off
Neauvia Stimulate
In stock
CE Marked
Neauvia Stimulate is a biodegradable hyaluronic acid filler cross-linked with PEG and enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy, intended to restore lost volume of the soft tissue and resorbed over time. It is placed in the subdermis and over the periosteum. The product contains 26 mg/mL of hyaluronic acid with a medium to high extrusion force, is enriched with glycine and L-proline and is intended for professional use. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market, and Stimulate was named Best Injectable Dermal Filler at the AMWC 2024 Awards.
主なメリット： Neauvia Stimulate
- 26 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- One of the only PEG-HA plus CaHA fillers on the market
- Named Best Injectable Dermal Filler at the AMWC 2024 Awards
- Studied over 24 weeks for correction of mid-face volume deficit
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
適応と専門的な使用
主な適応
- Restoration of lost volume of the soft tissue
- Correction of mid-face volume deficit
専門的な使用
For professional use. Neauvia Stimulate is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices, and it is the filler used in Neauvia's Nlift mid-face synergistic protocol.
施術部位
- Face
- Mid-face
対象となる患者
Suitable for adult patients presenting with age-related volume loss of the soft tissue, particularly mid-face volume deficit, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
作用の仕組み： Neauvia Stimulate
Stimulate combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. A 24-week post-market, observational, prospective, open-label, single-centre study reported that this formulation effectively addresses skin and subcutaneous tissue concerns, in particular the correction of disorders and of mid-face volume deficit, with the data highlighting an efficient mechanical effect of the PEGylated polymeric acid matrix enriched with low-concentration CaHA. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance. The gel is a temporary filling, with a 6 month degradation average time.
Allparaで注文する理由
Allparaは、正規品で検証済みの NEAUVIA 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。
よくある質問
How does Neauvia Stimulate differ from Neauvia Intense?
Composition and plane. Neauvia Stimulate carries 26 mg/mL hyaluronic acid enriched with calcium hydroxyapatite and is placed in the subdermis or over the periosteum. Neauvia Intense carries 28 mg/mL without CaHA and is placed in the subcutis or over the periosteum. The Stimulate line is the only one in the range to combine PEG-HA with CaHA.
Why does Neauvia Stimulate contain calcium hydroxyapatite?
A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue, in particular for correcting mid-face volume deficit.
その他の製品： Matex Lab S.P.A
ラボを見る →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.